|
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study |
|
|
|
Titel: |
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study |
Auteur: |
Xu, Jianming Shen, Lin Zhou, Zhiwei Li, Jie Bai, Chunmei Chi, Yihebali Li, Zhiping Xu, Nong Li, Enxiao Liu, Tianshu Bai, Yuxian Yuan, Ying Li, Xingya Wang, Xiuwen Chen, Jia Ying, Jieer Yu, Xianjun Qin, Shukui Yuan, Xianglin Zhang, Tao Deng, Yanhong Xiu, Dianrong Cheng, Ying Tao, Min Jia, Ru Wang, Wei Li, Jing Fan, Songhua Peng, Mengye Su, Weiguo |
Verschenen in: |
Lancet oncology |
Paginering: |
Jaargang 21 () nr. 11 pagina's 1500-1512 |
Jaar: |
2020 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|